Considerations for Pharmaceutical Research of Genome Editing Systems in Advanced Therapy Medicinal Products

Yin Huifang, Wei Xuejing, Dai Yifei, Ma Xiaojuan, Zhang Jingchen

Chinese Pharmaceutical Affairs ›› 2025, Vol. 39 ›› Issue (5) : 499-505.

PDF(1106 KB)
PDF(1106 KB)
Chinese Pharmaceutical Affairs ›› 2025, Vol. 39 ›› Issue (5) : 499-505. DOI: 10.16153/j.1002-7777.2024-12-0021
Supervision & Administration

Considerations for Pharmaceutical Research of Genome Editing Systems in Advanced Therapy Medicinal Products

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 39(5): 499-505 https://doi.org/10.16153/j.1002-7777.2024-12-0021

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1106 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉